New Delhi: India’s drug regulator has allowed The AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, News18 quoted Reuters as saying.
The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities to minimise vaccine wastage and better plan their inoculation programmes.
Some African countries have only until the middle of next month to use up more than a million doses of the vaccine branded Covishield by SII if the shelf life is not extended.
“You are permitted to apply the shelf-life of 9 months to unlabelled vials available on hand,” India’s drug controller-general, V.G. Somani, wrote late last month in reply to a request from the SII.
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…